Institutional Perspectives in Cancer- Immunotherapy: Chaired by Omid Hamid, MD


Institutional Perspectives in Cancer- Immunotherapy: Chaired by Omid Hamid, MD

Institutional Perspectives in Cancer- Immunotherapy: Chaired by Omid Hamid, MD

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.


  • Ani Balmanoukian, MD | Cedars-Sinai
  • Inderjit Mehmi, MD | Cedars-Sinai
  • Vi K. Chiu, MD, PHD | Cedars-Sinai
  • Kristopher P. Wentzel, MD | Cedars-Sinai


  • IO Therapy NSCLC
  • Melanoma Treatment
  • Role of IO in GI cancers
  • Current and Future Considerations in RCC and TCC bladder.

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Inderjit Mehmi, MD
Nathaniel Myall, MD
Martin Cannon, PhD, professor, Department of Microbiology, University of Arkansas for Medical Sciences College of Medicine
Pedro Barata, MD, MSc
Megan Hitchins, PhD
Elizabeth Buchbinder, MD
Institutional Perspectives in Cancer: Lung Cancer - Chaired by John V. Heymach, MD, PhD
Megan Hitchins, PhD
Karen L. Reckamp, MD, MS, professor of medicine, director, Division of Medical Oncology and Lung Institute, Cedars-Sinai Medical Center, associate director, Clinical Research, Cedars-Sinai Cancer Institute
Experts on GVHD
Related Content